Five-Year Experience in Treatment of Retinoblastoma with Intra-Arterial Chemotherapy: A Single-Center Analysis

PURPOSE: To report our 5-year experience in treating retinoblastoma (RB) with intra-arterial chemotherapy (IAC) as a primary or secondary therapy, without adjuvant intravitreal chemotherapy. METHODS: A retrospective study was conducted on 70 eyes with intraocular RB that were treated with primary or...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghassemi, Fariba, Dehghani, Shima, Mahmoudzadeh, Raziyeh, Khodabandeh, Alireza, Ghanaati, Hossein, Termehchi, Gholamreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772483/
https://www.ncbi.nlm.nih.gov/pubmed/35128196
http://dx.doi.org/10.4103/joco.joco_113_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772483/
https://www.ncbi.nlm.nih.gov/pubmed/35128196
http://dx.doi.org/10.4103/joco.joco_113_21

Ejemplares similares